Table of contents

Electronic pages

• 1: Association between peripheral nerve function and structure in human diabetic nerves (8 May, 2017)

  Adeniyi Borire, Tushar Issar, Natalie Kwai, Arun Krishnan
• 2: JC virus conversion rates in natalizumab treated patients: the melbourne longitudinal cohort study (8 May, 2017)

  Chris Dwyer, Vilija Jokubaitis, Josephine Baker, Jodi Haartsen, Louise Rath, Jennifer Coleman, Kylie Fryer, Jennifer Macintyre, Adriana Cartwright, Olga Skibina, Richard Macdonell, Ernest Butler, Neil Shuey, Helmut Butzkueven, Trevor Kilpatrick, Anneke van der Walt
• 3: Paramedic validation of an australian large vessel occlusion triage algorithm for stroke (8 May, 2017)

  Henry Zhao, Lauren Pesavento, Skye Coote, Leonid Churilov, Karen Smith, Stephen Bernard, Nawaf Yassi, Stephen M Davis, Bruce CV Campbell
• 4: Phenotypic variability in mnd: clues to site of origin and patterns of disease spread (8 May, 2017)

  Thanuja Dharmadasa, Jose M Matamala, Neil G Simon, Yuichi Noto, James Howells, Chenyu Wang, Michael Barnett, Steve Vucic, Matthew C Kiernan
• 5: High incidence of neurosyphilis in the ‘top end’ of australia: a systematic approach to its diagnosis (8 May, 2017)

  Prashanth Ramachandran, Ric N Price, James Burrow
• 6: Brain volume loss precedes cognitive decline in the first year after ischaemic stroke (8 May, 2017)

  Emilio Werden, Toby Cumming, Laura Bird, Mohamed Khlif, Amy Brodtmann
• 7: Intravenous thrombolysis and clot retrieval following reversal of dabigatran with idarucizumab (8 May, 2017)

  Dominic MY Tse, Laura Young, Anna M Ranta, PA Barber
• 8: Orthostatic tremor: disease progression and measuring disability (8 May, 2017)

  Nirosen Vijiaratnam, Darshana Sirisena, Eldho Paul, Kelly Bertram, David Williams
• 9: Australian driving restrictions: how well do neurologists know them? (8 May, 2017)

  Patricia Caruana, Andrew Hughes, Christian J Lueck
• 10: The prevalence of idiopathic intracranial hypertension and associated co-morbidities in central western new south wales (nsw) (8 May, 2017)

  Ivonne Lichtenberg, Emma Blackwood, James Gordon, Simon Hammond, Simon Hawke
• 11:

  A potential therapeutic for chronic pain from the new zealand native stinging nettle urtica ferox (ongaonga)

  (8 May, 2017)

  Eric J Buenz, Gareth J Parry, Brent A Bauer, Charles L Howe, Graeme Hammond-Tooke, Toyokazu Tsuchihara, Mami Kanzaki, Matthew Peacey
• 12: Serum metabolomic profiling for diagnosis of mitochondrial diseases (8 May, 2017)

  Ryan Davis, Anthony Dona, Joanna Pakiriah, Christina Liang, Fabienne Edema-Hildebrand, Carolyn Sue
• 13: The prognostic utility of no evidence of disease activity (neda) (8 May, 2017)

  Grace Lu, Heidi Beadnall, Chenyu Wang, Todd Hardy, Joshua Barton, Michael Barnett
• 14: Characterisation of tumefactive demyelinating lesions (8 May, 2017)

  Ariadna A Fontes-Villalba, Heath H French, John DE Parratt
• 15: The many faces of anti-glycine receptor related disease: a case series and literature review (8 May, 2017)

  Andrew Swayne, Linda Tjoa, Richard Wong, David Gillis, Daniel Schweitzer, Benjamin Tsang, Andrew McNabb, Simon Broadley, Stefan Blum
• 16: timing of high-efficacy disease modifying therapies for relapsing-remitting multiple sclerosis (8 May, 2017)

  Bernd Merkel, Vilija Jokubaitis, Tim Spelman, Jeannette Lechner-Scott, Pamela McCombe, Mark Slee, Steve Vucic, Olga Skibina, Michael Barnett, Suzanne Hodgkinson, Helmut Butzkueven, Tomas Kalincik
• 17: Comparing magnetic resonance imaging brain atrophy measurement techniques in multiple sclerosis clinical practice: longitudinal assessment (8 May, 2017)

  Heidi N Beadnall, Chenyu Wang, Wim Van Hecke, Annemie Ribbens, Michael H Barnett
• 18: Hypermetabolism in motor neurone disease is associated with a greater functional decline but not weight loss (8 May, 2017)

  Zara A Ioannides, Shyuan T Ngo, Robert D Henderson, Pamela A McCombe, Frederik J Steyn
• 19: Imbalance in cortical inhibition-excitation networks underlies als (8 May, 2017)

  Mehdi AJ Van den Bos, Nimeshan Geevasinga, Parvathi Menon, Matthew C Kiernan, Steve Vucic
• 20: Cortical hyperexcitability may contribute to disease spread in als (8 May, 2017)

  Parvathi Menon, Nimeshan Geevasinga, Mehdi Van den Bos, Con Yiannikas, Matthew C Kiernan, Steve Vucic
• 21: Functional and structural connectivity in als: insights from mri connectome analyses and tms (8 May, 2017)

  Nimeshan Geevasinga, Mayuresh korgaonkar, Parvathi Menon, Mehdi Van Den Bos, Lavier Gomes, Sheryl Forster, Matthew Kiernan, Steve Vucic
• 22: Energy expenditure in frontotemporal dementia: a behavioural and imaging study (8 May, 2017)

  Rebekah M Ahmed, Ramon Landin-romero, Tinh-Hai Collette, Agatha Van der Klaauw, Emma Devenney, Elana Henning, Olivier Piguet, Sadaf Farooqi, John R Hodges, Matthew C Kiernan
• 23: The hummingbird identifies psp among patients with non-fluent primary progressive aphasia (8 May, 2017)

  Matthew Silsby, Ry Tweedie-Cullen, Cynthia R Murray, Glenda M Halliday, John R Hodges, James R Burrell
• 24: Psychological interventions for psychogenic non-epileptic seizures: a meta-analysis (8 May, 2017)

  Perri Carlson, Kathryn Nicholson Perry
• 25: A better mbs for all australians (8 May, 2017)

  Bruce Robinson
• 26: Efficacy and safety of teriflunomide in chinese patients with relapsing forms of ms: a subgroup analysis of the phase 3 tower study (8 May, 2017)

  Richard Macdonell, Mark S Freedman, Xianhao Xu, Steve Vucic, Philippe Truffinet, Myriam Benamor, Karthinathan Thangavelu, Aaron E Miller
• 27: Myasthenia gravis with an unusual pattern of weakness and positive igg anti gm1 antibody (8 May, 2017)

  Jo Lyn Ng, Wai Foong Hooi, Abhishek Malhotra, Paul Talman
• 28: A potential 40% cost savings through treating cidp with tpe instead of ivig (8 May, 2017)

  Gareth J Parry, Eric J Buenz, Anna Ranta
• 29: Screening for cognitive and behavioural impairment in patients with amyotrophic lateral sclerosis: frequency of abnormality and effect on survival (8 May, 2017)

  Zhouwei Xu, Ashwag Alruwaili, Robert Henderson, Pamela McCombe
• 30: Ketogenic diet to manage refractory epilepsy in the cdkl5 disorder (8 May, 2017)

  Zhan Lim, Jenny Downs, Kingsley Wong, Helen Leonard
• 31: Listeria rhomboencephalomyelitis complicated by haemorrhagic transformation (8 May, 2017)

  Benjamin Nham, Johnathan Baskin, Ho Choong
• 32: Subacute myopathy as the initial presentation of anca positive vasculitis associated with crohn’s disease (8 May, 2017)

  Benjamin Nham, Roger Pamphlett, Karuna Keat, Vishal Patel
• 33: Radiology ruse: dural venous sinus cyst masquerading as venous sinus thrombosis presenting with headache and stroke (8 May, 2017)

  Christopher McAulay-Powell, Alexandra Murton, Wei-Che Tsai, Dean Jones, Jens Froelich
• 34: Gelsolin, clusterin and cd5l are the potential plasma biomarkers of amyotrophic lateral sclerosis with and without cognitive impairment (8 May, 2017)

  Zhouwei Xu, Aven Lee, Robert Henderson, Pamela McCombe
• 35: The risk of overestimating fatness in motor neurone disease: longitudinal assessments of body composition (8 May, 2017)

  Zara A Ioannides, Frederik J Steyn, Robert D Henderson, Pamela A McCombe, Shyuan T Ngo
• 36: Demyelinating disease with antibodies to myelin oligodendrocyte glycoprotein (mog) presenting as nmo (8 May, 2017)

  Desiree Fernandez, Gareth Parry
• 37: Dream a little dream: an update on genetics guided therapy for stroke in australia (8 May, 2017)

  Kate Johnson, Sameen Haque, Mohamed Shaffi
• 38: Co-occurrence of cadasil and a parkinsonian syndrome: a report of two cases and review of the literature (8 May, 2017)

  Natalia Murray, Elizabeth Pepper, Jeff Blackie, Anne Ronan, Ella Sugo
• 39: Artery of percheron occlusion causing bilateral thalamic ischaemic infarcts (8 May, 2017)

  Stephanie Barnes, Nandini Singh, Dayna Griffiths
• 40: Muscle membrane dysfunction in inclusion body myopathy studied by muscle velocity recovery cycles (8 May, 2017)

  James H Lee, Robert Boland-Freitas, Christina Liang, Karl Ng
• 41: Transcranial magnetic stimulation in patients with functional limb weakness (8 May, 2017)

  Benson S Chen, P Alan Barber, Cathy M Stinear
• 42: The efficacy of vestibular rehabilitation in people reporting dizziness with multiple sclerosis: a systematic review and meta-analysis (8 May, 2017)

  Joseph Danicic, Katrina Williams, Adam Semciw, Emma Henneken
• 43: The relationship between diagnosis acceptance, self-concept, and mental health outcomes in individuals with multiple sclerosis (8 May, 2017)

  Natalie Kate Ward, Litza A Kiropoulos
• 44: Myasthenia gravis associated with nivolumab therapy in patient with lung adenocarcinoma (8 May, 2017)

  Suji Prabhaharan, Abhishek Joshi, Ravindra Urkude
• 45: Organophosphate induced delayed pure motor neuropathy (8 May, 2017)

  Abhiranjan Shukla, Dharampal Anand, Ravindra Urkude
• 46: The international clinical outcome study in dysferlinopathy (8 May, 2017)

  Roula Ghaoui, James Meredith, Roberto Fernandez-Torron, Ursula Moore, Jordi Diaz-Manera, Fiona E Smith, Anna Mayhew, Kristi J Jones, The Jain COS Consortium, Kate Bushby, Volker Straub
• 47: Treatment satisfaction in patients with rrms treated with teriflunomide in routine clinical practice: aubpro study design (8 May, 2017)

  Steve Vucic, Michael H Barnett, Stefan Blum, Neil Shuey, Richard Worrell, Richard Macdonell
• 48: Reversible leukoencephalopathy complicating a methotrexate ommaya reservoir (8 May, 2017)

  Michal Lubomski, Malcolm Pell, Alistair Lochhead, Martin Jude
• 49: Artery of percheron occlusion: a rare cause of coma (8 May, 2017)

  Shadi El-Wahsh, Dinushi Weerasinghe, Alan McDougall
• 50: Alemtuzumab in refractory chronic inflammatory demyelinating polyneuropathy (8 May, 2017)

  Wendy Wang, Christopher McAulay-Powell, Michael Dreyer, Bruce Taylor
• 51: Histopathological neurosarcoidosis in response to disseminated seminoma with absence of central nervous system metastases (8 May, 2017)

  Jennifer Massey, John Parratt
• 52: Cytotoxic activity and calcium signalling in natural killer cells in multiple sclerosis (8 May, 2017)

  Laura Clarke, Simon Broadley, Thao Nguyen, Samantha Johnston, Donald Staines, Sonya Marshall-Gradisnik
• 53: Sarcolemmal excitability attributes of the myotonic dystrophies as assessed by muscle velocity recovery cycles (mvrcs) (8 May, 2017)

  Robert Boland-Freitas, James Howells, James Lee, Christina Liang, Alastair Corbett, Garth Nicholson, Karl Ng
• 54: TNF-alpha inhibitor therapy associated demyelination (8 May, 2017)

  James D Triplett, Allan G Kermode
• 55: Acute seizure management in a private hospital (8 May, 2017)

  Emma Foster, Patrick Kwan
• 56: Epithelioid haemangioendothelioma: a rare mimic of nerve tumours (8 May, 2017)

  James D Triplett, Allan G Kermode
• 57: Pattern and impact of pain in a national survey of genetic muscle disease (8 May, 2017)

  Shilpan G Patel, Richard Roxburgh, M Rodrigues, K Walker, G O’grady, G Poke, D Love, P Parmar, G Hammond-Tooke, B Te Ao, Alice Theadom
• 58: Tolosa-hunt syndrome associated severe internal carotid artery stenosis resulting in cerebral infarcts (8 May, 2017)

  James D Triplett, Thomas Chemmanam
• 59: Peripheral nerve ultrasound in friedreich’s ataxia (8 May, 2017)

  Eoin Mulroy, Luciana Pelosi, Purwa Joshi, Ruth Leadbetter, Miriam Rodrigues, Stuart Mossman, Richard Roxburgh
• 60:

  The real-world efficacy of botulinum toxin type a (botox^®) for the prophylaxis of headaches in adult patients with chronic migraine in australian clinical practice: a retrospective chart review

  (8 May, 2017)

  Catherine Stark, Richard Stark, Nicole Limberg, Colin Andrews, Julian Rodrigues, Dennis Cordato, Raymond Schwartz, Frost J Michelle, Tan Jonathan
• 61: Endovascular clot retrieval for acute stroke in outer metropolitan sydney (8 May, 2017)

  Kieren Po, Salman Khan
• 62: Phase 3, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab (amg 334) in migraine prevention: primary results of the strive trial (8 May, 2017)

  Peter J Goadsby, Uwe Reuter, Jo Bonner, Gregor Broessner, Yngve Hallstrom, Feng Zhang, Sandhya Sapra, Hernan Picard, Daniel Mikol, Robert Lenz
• 63: A phase 3, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab in migraine prevention: primary results of the arise trial (8 May, 2017)

  David Dodick, Messoud Ashina, David Kudrow, Michel Lanteri-Minet, Vera Osipova, Kerry Palmer, Hernan Picard, Daniel D Mikol, Robert A Lenz
• 64: Glycaemic chorea (8 May, 2017)

  Chani Tromop-van Dalen, David Bourke, Ian Rosemergy
• 65: Age-related differences in muscle membrane polarisation as assessed by velocity recovery cycles (8 May, 2017)

  James H Lee, Robert Boland-Freitas, Karl Ng
• 66: An evaluation of acute stroke ct protocol requests made in the emergency department (8 May, 2017)

  Aicee Calma, Yash Gawarikar, Ronak Patel
• 67: Focal seizure with transient asymmetrical cortical and subarachnoid enhancement on computed tomography following iodinated contrast administration (8 May, 2017)

  Kieren Po, Gabrielle James, Radha Popuri, Pramod Phadke, Jerome Ip
• 68: Post-vaccine gbs variant manifesting as polyneuritis cranialis and polyradiculopathy (8 May, 2017)

  Wai Foong Hooi, Abhishek Malhotra
• 69:

  Single heterozygous mutations in atp13a2 cause mitochondrial dysfunction

  (8 May, 2017)

  Jin Sung Park, Christine Klein, Carolyn M Sue
• 70: Fibroelastoma: a rare cause of cardioembolic stroke in the young (8 May, 2017)

  Srimathy Vijayan, William Carroll
• 71: Poems masquerading as treatment refractory cidp: a case series (8 May, 2017)

  Benjamin Nham, Christina Brown, Lianne Khoo, John Gibson, Judith Spies, Stacey Jankelowitz
• 72: Too much of a good thing: a case report detailing two instances of cerebral hyperperfusion syndrome (8 May, 2017)

  Alexandru Colibaba, Aicee Calma, Shaun Zhai, Yash Gawarikar, Christian Lueck
• 73: Large vessel vasculitis: a rare cause of isolated lower limb myopathy (8 May, 2017)

  Shadi El-Wahsh, Dinushi Weerasinghe, Alan McDougall
• 74: A rare case of csf xanthochromia due to severe disc protrusion resulting in froin’s syndrome (8 May, 2017)

  Gaurav Singh, Andrew Swayne, Stefan Blum, Alex Lehn, Helen Brown, Cullen O’Gorman
• 75: Isolated cranial nerve and autonomic dysfunction: an uncommon variant of gbs (8 May, 2017)

  Lin Zhang, Sanjeev Taneja
• 76: ‘fawlty’ haemodynamic regulation: a case of gelastic syncope (8 May, 2017)

  Joel Corbett, Cullen O’Gorman
• 77: Asymmetry of cerebral microbleeds and superficial siderosis in cerebral amyloid angiopathy (8 May, 2017)

  Rohit Sharma, Dean McKenzie, Stephanie Dearaugo, Bernard Infeld, Richard O’Sullivan, Richard P Gerraty
• 78: Central nervous system lymphomatoid granulomatosis without pulmonary involvement: a case report (8 May, 2017)

  David L-Y Wong, Alexander C Lehn
• 79: Establishment of the first at-home natalizumab infusion service for the treatment of relapsing remitting multiple sclerosis (rmms) (8 May, 2017)

  Srimathy Vijayan, Julie Adams, Lorna Cook, Zelda Haskins, Allan Kermode
• 80: A survey of patient perceptions of tele-epilepsy services in north queensland (8 May, 2017)

  Sarah Adamson, Michelle Smit, Craig Costello
• 81: Comparison of faecal microbe diversity between motor neurone disease (mnd) and control participants (8 May, 2017)

  Frederik J Steyn, Restuadi Restuadi, Zara Ioannides, Shyuan T Ngo, Allan McRae, Naomi R Wray, Robert Henderson, Pamela McCombe
• 82: Anti-nmda receptor encephalitis complicating hsv encephalitis with demonstrated seroconversion (8 May, 2017)

  Andrew Swayne, Helen Brown, Gaurav Singh, Stefan Blum
• 83: Evaluation of no evidence of progression or active disease (nepad) in patients with primary progressive multiple sclerosis in the oratorio trial (8 May, 2017)

  Jerry Wolinsky, Xavier Montalban, Ludwig Kappos, Stephen Hauser, Gavin Giovannoni, Jerome de Seze, Amit Bar-Or, Donna Masterman, Corrado Bernasconi, Wei Wei, Hideki Garren, Peter Chin, Shibeshih Belachew, Doug L Arnold
• 84: A case of severe optic neuropathy caused by biopsy proven cll without peripheral transformation with excellent treatment response to rituximab, obinutuzumab (second generation anti-cd20 monoclonal antibody) and chlorambucil (8 May, 2017)

  Divita Jhaveri, Andrew Swayne, Helen Brown, Caroline Airey
• 85: A case of autoimmune myositis after alemtuzumab therapy for multiple sclerosis (8 May, 2017)

  Patrick Aouad, Con Yiannikas, John Parratt
• 86: Treatment responsive reversible cerebral vasoconstriction syndrome with features of psychosis and large intracerebral haemorrhage (8 May, 2017)

  Francesca Dowland, Andrew Swayne, Sandeep Bhuta, Peter Bailey, Arman Sabet
• 87: Treatment of autoimmune encephalitis with immune based therapies (8 May, 2017)

  Francesca Dowland, Andrew Swayne, Sandeep Bhuta, Arman Sabet, Simon Broadley
• 88: Preliminary results of the opera i and opera ii open-label extension study (8 May, 2017)

  Robert Naismith, Mark Cascione, Luigi Grimaldi, Stephen Hauser, Ludwig Kappos, Xavier Montalban, Jerry Wolinsky, Peter Chin, Hideki Garren, Laura Julian, Fabian Model, David Honeycutt
• 89: Toxocara encephalomyelitis: a case report (8 May, 2017)

  Michael J Devlin, Caroline Airey
• 90: Punctate enhancement in a patient with neurosarcoidosis: a challenging radiological pattern (8 May, 2017)

  Ariadna A Fontes-Villalba, John DE Parratt
• 91: Autoimmune thyroid disease in the setting of treatment for ms with alemtuzumab (8 May, 2017)

  Elham Khalilidehkordi, Laura Clarke, Sofia Jimenez Sanchez, Meaghan Osborne, Simon Broadley
• 92: Vitamin D in the treatment of multiple sclerosis: A meta-analysis (8 May, 2017)

  Laurie Mclaughlin, Laura Clarke, Elham Khalilidehkordi, Helmut Butzkueven, Bruce Taylor, Simon Broadley
• 93: Cross sectional peripheral nerve area in cerebellar ataxia neuropathy vestibular areflexia syndrome (canvas) (8 May, 2017)

  Luciana Pelosi, Eoin Mulroy, Ruth Leadbetter, Dean Kilfoyle, Andrew Chancellor, Stuart Mossman, Richard Roxburgh
• 94: Neurological complication related to atrial myxomas (8 May, 2017)

  Jonathan Baird-Gunning, Shivendra Lalloo, Christian J Lueck, Chandi Das
• 95: N-of-1 trial of thymoquinone and vorinostat in a patient with sialidosis type 1 (8 May, 2017)

  Christina Liang, D Peach, Samantha Stark, Michael Fietz
• 96: Transient vertigo preceding vestibular neuritis (8 May, 2017)

  Richard P Gerraty, Hayley Roberts, Kunal Luthra, Bernard Infeld, Renee Bruce
• 97: Multiple bithalamic microbleeds in a case of deep cerebral dural arteriovenous fistula (8 May, 2017)

  Andrew Clarke, Wilson Vallat, Timothy Kleinig
• 98: Miller fisher syndrome presenting with prodromal thunderclap headache (8 May, 2017)

  Michael J Waters, Michelle Kiley
• 99: Cacna1a mutation presenting with focal dystonia (8 May, 2017)

  Jason Gu, Kishore R Kumar, Carolyn M Sue
• 100: The impact of location, time and practice effects on computerised cognitive testing using msreactor in people with multiple sclerosis (8 May, 2017)

  Anneke Van der Walt, Daniel Merlo, Tomas Kalincik, Jodi Haartsen, David G Darby, Helmut Butzkueven
• 101: Eosinophilic meningoencephalitis due to angiostronglyus infection (8 May, 2017)

  Manisha Narasimhan, Omar Shum, Robert Stevens, Lynette Masters
• 102: Development of an international electronic database for research into neuroimmunological diseases (enid) (8 May, 2017)

  Katherine Buzzard, Stephen W Reddel, Sean Riminton, Helmut Butzkueven